Reperfusion injury: Experimental evidence and clinical implications

American Heart Journal

Volumn 138, Issue 2 II, 1999, Pages

  Ambrosio, G ^a   Tritto, I ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN RADICAL;

EXPERIMENTAL MODEL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE INJURY;

EID: 0032776548     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70323-6     Document Type: Article

References (50)

1. Becker LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987;30:23-41.
2. Ambrosio G, Flaherty JT, Duilio C, et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991;87:2056-66.
3. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 1987;84:1404-7.
4. Bolli R, Jeroudi MO, Patel BS, et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci U S A 1989;86:4695-9.
5. Ambrosio G, Zweier JL, Flaherty JT. The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion. J Mol Cell Cardiol 1991;23:1359-460.
6. Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 1989;65:607-22.
7. Ambrosio G, Weisman HF, Mannisi JA, et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1846-61.
8. Ferrari R, Ceconi C, Curello S, et al. Oxygen-mediated myocardial damage during ischemia and reperfusion: role of the cellular defenses against oxygen toxicity. J Mol Cell Cardiol 1985;17:937-45.
9. Duilio C, Ambrosio G, Kuppusamy P, et al. In vivo evidence that neutrophils become activated and generate oxygen radicals in reperfused hearts [abstract]. J Am Coll Cardiol 1996;27:33A.
10. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
11. Entman ML, Smith WC. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-11.
12. Simpson PJ, Mitsos SE, Ventura A, et al. Prostacyclin protects ischemic-reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987;113:129-37.
13. Simpson PJ, Todd RF III, Fantone JC, et al. Reduction of experimental canine myocardial reperfusion injury by a monoclonal, antibody (anti Mo1, anti CD11b) that inhibits leukocyte function. J Clin Invest 1988;81:624-9.
14. Romson JL, Hook BJ, Kunkel SL, et al. Reduction in the extent of ischemic injury by neutrophil depletion in the dog. Circulation 1983;67:1016-23.
15. Romaschin AD, Wilson GJ, Thomas U, et al. Subcellular distribution of peroxidized lipids in myocardial reperfusion injury. Am J Physiol 1990;259:H116-23.
16. Oldroyd KG, Chopra M, Rankin AC, et al. Lipid peroxidation during myocardial ischaemia induced by pacing. Br Heart J 1990;63:88-92.
17. Ferreira R, Burgos M, Llesuy S, et al. Reduction of reperfusion injury with mannitol cardioplegia. Ann Thorac Surg 1989;48:77-84.
18. Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990;81:201-11.
19. Guarnieri C, Muscari C, Ceconi C, et al. Effect of superoxide generation on rat heart mitochondrial pyruvate utilization. J Mol Cell Cardiol 1983;15:859-66.
20. Shlafer M, Kane PF, Kirsh MM. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 1982;83:830-9.
21. Ambrosio G, Weisfeldt ML, Jacobus WE, et al. Evidence for a reversible, oxygen radical mediated component of reperfusion damage: reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 1987;75:282-91.
22. Gryglewsky RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-6.
23. Gasic AC, McGuire G, Krater S, et al. Hydrogen peroxide pretreatment of perfused canine vessels induce ICAM-1 and CD18-dependent neutrophil adherence. Circulation 1991;84:2154-66.
24. Lewis MS, Whatley RE, Cain P, et al. Hydrogen peroxide stimulates the synthesis of platelet activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988;82:2045-55.
25. Ambrosio G, Oriente A, Napoli C, et al. Oxygen radicals inactivate human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J Clin Invest 1994;93:2408-12.
26. Petrone WF, English DK, Wong K, et al. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci U S A 1980;77;1159-63.
27. Golino P, Ragni M, Cirillo P, et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996;2:35-40.
28. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950-61.
29. Mehta JL, Nichols WW, Saldeen GP, et al. Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator. J Cardiovasc Pharmacol 1980;16:112-20.
30. Puett DW, Forman MB, Cates CU, et al. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation 1987;76:678-86.
31. Nejima J, Knight DR, Fallon JT, et al. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989;79:143-53.
32. Przyklenk K, Kloner RA. "Reperfusion injury" by oxygen-derived free radicals? Effects of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 1989;64:86-96.
33. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982;65:1497-503.
34. Mathias P, Kerin NZ, Blevins RD, et al. Coronary vasospasm as a cause of stunned myocardium. Am Heart J 1987;113:383-5.
35. Stack RS, Phillips HR III, Grierson DS, et al. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J Clin Invest 1983;72:84-95.
36. Schmidt WG, Sheehan FH, von Essen R, et al. Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction. Am J Cardiol 1989;63:497-502.
37. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary artery bypass surgery. J Am Coll Cardiol 1990;15:1261-9.
38. Ballantyne CM, Verano MS, Short HD, et al. Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery. J Am Coll Cardiol 1987;10:710-2.
39. Ambrosio G, Betocchi S, Pace L, et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: evidence of myocardial stunning in patients with coronary artery disease. Circulation 1996;94:2455-61.
40. Johnson WD, Kayser KL, Brenowitz JB, et al. A randomized controlled trial of allopurinol in coronary bypass surgery. Am Heart J 1991;121:20-4.
41. Flaherty JT, Pitt B, Gruber JW, et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1994;89:1982-91.
42. Forman MB, Perry JM, Wilson BH, et al. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol 1991;18:911-8.
43. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
44. Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the "noreflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985;5:593-8.
45. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
46. Olafsson B, Forman MB, Puett DW, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1986;76:1135-42.
47. Kolodgie FD, Virmani R, Farb A. Limitation of no-reflow injury by blood-free reperfusion with oxygenated perfluorochemicals (Fluosol-DA 20%). J Am Coll Cardiol 1991;18:215-23.
48. Villari B, Ambrosio G, Golino P, et al. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. Am Heart J 1993;125:11-9.
49. Marzilli M, Marraccini P, Gliozheni E, et al. Intracoronary adenosine as an adjunct to combined use of primary angioplasty in acute myocardial infarction: beneficial effects on angiographically assessed no-reflow [abstract]. J Am Coll Cardiol 1996; 27:81A.
50. Memmola C, Biasco G, Marangelli V, et al. Early intravenous administration of verapamil in thrombolised acute anterior myocardial infarction: beneficial effect on left ventricular remodelling and clinical outcome [abstract]. Eur Heart J 1998;19(abstract suppl):475.